Cart
sales@molnova.com
Coblopasvir dihydrochloride
CAS No. 1966138-53-3
Coblopasvir dihydrochloride( Coblopasvir dihydrochloride(1312608-46-0 Free base) )
Catalog No. M27811 CAS No. 1966138-53-3
Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 297 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 306 | In Stock |
|
| 25MG | 519 | In Stock |
|
| 50MG | 727 | In Stock |
|
| 100MG | 995 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCoblopasvir dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCoblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor.
-
DescriptionCoblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsCoblopasvir dihydrochloride(1312608-46-0 Free base)
-
PathwayMicrobiology/Virology
-
TargetHCV
-
Recptor5-HT3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1966138-53-3
-
Formula Weight855.81
-
Molecular FormulaC41H52Cl2N8O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (58.42 mM)
-
SMILESO=C(OC)N[C@@H](C(N1[C@@H](C2=NC=C(C3=CC=C(C4=C5OCOC5=C(C6=CN=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC7)N6)C=C4)C=C3)N2)CCC1)=O)C(C)C.[H]Cl.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Faria C, et al. Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis. Am Health Drug Benefits. 2014 Jan;7(1):50-8.
molnova catalog
related products
-
Pibrentasvir
Pibrentasvir (ABT-530) is a novel and pan-genotypic HCV NS5A inhibitor with EC50 of 1.4-5.0 pM against HCV replicons containing NS5A genotypes 1-6.
-
VX-222
A potent and selective, nonnucleoside inhibitor of HCV NS5B polymerase inhibitor with Kd of 17 nM.
-
GS-9451
GS-9451 (Vedroprevir) is a potent HCV NS3/4A protease inhibitor with Ki of 0.41 nM, inhibits HCV GT-1b NS3/4A with IC50 of 3.2 nM in enzymatic assays.
